160 related articles for article (PubMed ID: 6131551)
21. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
Bone Marrow Transplant; 1997 Dec; 20(12):1105-7. PubMed ID: 9466287
[TBL] [Abstract][Full Text] [Related]
22. [Extensive plasma exchange in ABO-incompatible bone marrow transplantation ].
Osterwalder B; Gratwohl A; Bannert P; Müller M; Nissen C; Burri HP; Speck B
Ther Umsch; 1982 Jul; 39(7):519-23. PubMed ID: 6750836
[No Abstract] [Full Text] [Related]
23. Early appearance of anti-A isohemagglutinin after allogeneic, ABO minor incompatible, T cell depleted bone marrow transplant.
Robertson VM; Henslee PJ; Jennings CD; Hill MG; Thompson JT; Dickson LG
Transplant Proc; 1987 Dec; 19(6):4612-7. PubMed ID: 3321632
[No Abstract] [Full Text] [Related]
24. [A simple and cell-sparing method for obtaining stem cells slightly contaminated by erythrocytes in bone marrow transplantation with major ABO incompatibility].
Mayer G; Sugg U; Wernet D; Schneider W
Beitr Infusionther Klin Ernahr; 1987; 18():316-20. PubMed ID: 3326590
[No Abstract] [Full Text] [Related]
25. Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption.
Rabitsch W; Knöbl P; Prinz E; Keil F; Greinix H; Kalhs P; Worel N; Jansen M; Hörl WH; Derfler K
Bone Marrow Transplant; 2003 Nov; 32(10):1015-9. PubMed ID: 14595389
[TBL] [Abstract][Full Text] [Related]
26. AB0-incompatible allogeneic hematopoietic stem cell transplantation.
Worel N; Kalhs P
Haematologica; 2008 Nov; 93(11):1605-7. PubMed ID: 18978296
[No Abstract] [Full Text] [Related]
27. [ABO incompatibility in allogeneic bone marrow transplantation].
Quabeck K; Beelen DW; Mahmoud HK; Schaefer UW; Schmidt CG; Henneberg-Quester KB; Luboldt W
Beitr Infusionther Klin Ernahr; 1987; 18():310-5. PubMed ID: 3326589
[No Abstract] [Full Text] [Related]
28. [ABO incompatibility and non myeloablative allogeneic stem cell transplantation].
Malfuson JV; Hicheri Y; Bonin P; Rodet M; Boccaccio C; Pautas C; Kuentz M; Cordonnier C; Noizat-Pirenne F; Maury S
Transfus Clin Biol; 2007 Aug; 14(3):327-33. PubMed ID: 17462938
[TBL] [Abstract][Full Text] [Related]
29. Immunohematologic problems arising from ABO incompatible bone marrow transplantation.
Sniecinski IJ; Petz LD; Oien L; Blume KG
Transplant Proc; 1987 Dec; 19(6):4609-11. PubMed ID: 3321631
[No Abstract] [Full Text] [Related]
30. Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion.
Verholen F; Stalder M; Helg C; Chalandon Y
Eur J Haematol; 2004 Dec; 73(6):441-6. PubMed ID: 15522068
[TBL] [Abstract][Full Text] [Related]
31. [Massive hemolysis following allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility].
Ishiyama M; Iwabe K; Hida M; Okamura T; Yoshinaga K; Hidai H; Kobayashi S; Sameshima Y; Mori N; Teramura M; Masuda M; Motoji T; Mizoguchi H
Rinsho Ketsueki; 2002 Jun; 43(6):477-81. PubMed ID: 12134705
[TBL] [Abstract][Full Text] [Related]
32. [Application of double-filtration plasmapheresis in major ABO-incompatible unrelated bone marrow transplantation].
Huang T; Sun J; Liu J; Liu QF; Men FY
Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1438-40. PubMed ID: 16305976
[TBL] [Abstract][Full Text] [Related]
33. Red cell salvage and reinfusion in pediatric bone marrow donors.
Kletzel M; Olszewski M; Danner-Koptik K; Coyne K; Haut P
Bone Marrow Transplant; 1999 Aug; 24(4):385-8. PubMed ID: 10467327
[TBL] [Abstract][Full Text] [Related]
34. Is the ABO incompatibility a risk factor in bone marrow transplantation?
Rozman P; Kosir A; Bohinjec M
Transpl Immunol; 2005 Aug; 14(3-4):159-69. PubMed ID: 15982558
[TBL] [Abstract][Full Text] [Related]
35. [Bone marrow transplantation with major ABO incompatibility. Experience at the bone marrow transplantation unit of the Center of Lisbon at the IPOFG].
Coelho R; Cunha I; Nolasco I; Machado A; Abecassis M
Acta Med Port; 1993 Feb; 6(2):79-81. PubMed ID: 8488766
[TBL] [Abstract][Full Text] [Related]
36. ABO incompatibility and relapse risk in patients undergoing allogeneic marrow transplantation for acute myeloid leukemia.
Mielcarek M; Torok-Storb B; Storb R
Bone Marrow Transplant; 2002 Oct; 30(8):547-8; author reply 548. PubMed ID: 12379898
[No Abstract] [Full Text] [Related]
37. Treatment of resistant pure red cell aplasia after major ABO-incompatible bone marrow transplantation with human adipose tissue-derived mesenchymal stem cells.
Fang B; Song Y; Zhao RC; Han Q; Cao Y
Am J Hematol; 2007 Aug; 82(8):772-3. PubMed ID: 17573692
[No Abstract] [Full Text] [Related]
38. [Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation].
Huang XJ; Liu DH; Xu LP; Han W; Jiang Q; Chen YH; Zhang YC; Liu KY; Bao L; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):548-50. PubMed ID: 16468333
[TBL] [Abstract][Full Text] [Related]
39. Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide.
Kalaycioglu M; Copelan E; Avalos B; Klein J; Goormastic M; Bolwell B
Bone Marrow Transplant; 1995 Jan; 15(1):105-10. PubMed ID: 7742742
[TBL] [Abstract][Full Text] [Related]
40. Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow.
Bär BM; Van Dijk BA; Schattenberg A; de Man AJ; Kunst VA; de Witte T
Bone Marrow Transplant; 1995 Dec; 16(6):793-9. PubMed ID: 8750272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
